Serum soluble CD23 levels in giant cell arteritis

Immunol Lett. 1996 Oct;53(1):41-4. doi: 10.1016/0165-2478(96)02612-0.

Abstract

Lymphocytes and monocytes express various levels of membrane-bound CD23, the low affinity receptor for IgE (Fc epsilon RII), and in some cases release it as a soluble form. Soluble CD23 (sCD23) has been implicated in the regulation of many immunological functions of T and B lymphocytes, macrophages and myeloid cells in humans. To study serum sCD23 levels in inflammatory conditions, we selected a systemic disease sensitive to corticotherapy, the giant cell arteritis, which is characterized by an inflammation of the temporal artery. Serum sCD23 levels, as measured by a radioimmunoassay, were increased in these patients, and returned to normal values within the 24 h following initiation of corticotherapy. The data suggest that the increase in sCD23 levels in giant cell arteritis results from an overproduction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Giant Cell Arteritis / blood
  • Giant Cell Arteritis / drug therapy
  • Giant Cell Arteritis / immunology*
  • Humans
  • Prednisone / therapeutic use*
  • Receptors, IgE / blood*
  • Solubility

Substances

  • Receptors, IgE
  • Prednisone